Sarah Gerver

1.6k total citations · 2 hit papers
34 papers, 1.0k citations indexed

About

Sarah Gerver is a scholar working on Infectious Diseases, Applied Microbiology and Biotechnology and Epidemiology. According to data from OpenAlex, Sarah Gerver has authored 34 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 15 papers in Applied Microbiology and Biotechnology and 13 papers in Epidemiology. Recurrent topics in Sarah Gerver's work include Antibiotic Use and Resistance (15 papers), HIV/AIDS Research and Interventions (8 papers) and Antibiotic Resistance in Bacteria (7 papers). Sarah Gerver is often cited by papers focused on Antibiotic Use and Resistance (15 papers), HIV/AIDS Research and Interventions (8 papers) and Antibiotic Resistance in Bacteria (7 papers). Sarah Gerver collaborates with scholars based in United Kingdom, United States and Jamaica. Sarah Gerver's co-authors include Helen Ward, Sarah Fidler, Sung-Hee Kim, Philippa Easterbrook, Gillian Elam, Ijeoma Solarin, Kevin Fenton, Russell Hope, Logan Manikam and Colin Brown and has published in prestigious journals such as SHILAP Revista de lepidopterología, Social Science & Medicine and AIDS.

In The Last Decade

Sarah Gerver

31 papers receiving 985 citations

Hit Papers

Adherence to antiretroviral therapy in adolescents living... 2014 2026 2018 2022 2014 2023 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Adherence to antiretroviral therapy in adolescents living with HIV
    2014 308 citations Sung-Hee Kim, Sarah Gerver et al. AIDS profile →
  2. Increase in invasive group A streptococcal infection notifications, England, 2022
    2023 88 citations Rebecca Guy, Katherine L. Henderson et al. Eurosurveillance profile →

Peers

Sarah Gerver
Esther Buregyeya Uganda
Alicen B. Spaulding United States
Joseph I. Harwell United States
Nimalie D. Stone United States
Setegn Eshetie Ethiopia
Margaret Pereyra United States
Stacey Knobler United States
James S. Ngocho Tanzania
Workeabeba Abebe Ethiopia
Vonthanak Saphonn Cambodia
Esther Buregyeya Uganda
Sarah Gerver
Citations per year, relative to Sarah Gerver Sarah Gerver (= 1×) peers Esther Buregyeya

Countries citing papers authored by Sarah Gerver

Since Specialization
Citations

This map shows the geographic impact of Sarah Gerver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Gerver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Gerver more than expected).

Fields of papers citing papers by Sarah Gerver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Gerver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Gerver. The network helps show where Sarah Gerver may publish in the future.

Co-authorship network of co-authors of Sarah Gerver

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Gerver. A scholar is included among the top collaborators of Sarah Gerver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Gerver. Sarah Gerver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guy, Rebecca, Katie L. Hopkins, Emma Budd, et al.. (2025). The importance of monitoring a new antibiotic: ceftazidime/avibactam usage and resistance experience from England, 2016 to 2020. Eurosurveillance. 30(14).
2.
3.
Beech, Elizabeth, Colin Brown, Alicia Demirjian, et al.. (2024). Trends in urine sampling rates of general practice patients with suspected lower urinary tract infections in England, 2015–2022: a population-based study. BMJ Open. 14(8). e084485–e084485. 1 indexed citations
4.
Henderson, Karen, Ayoub Saei, Ana Johnson, et al.. (2023). Intermittent point prevalence surveys on healthcare-associated infections, 2011 and 2016, in England: what are the surveillance and intervention priorities?. Journal of Hospital Infection. 140. 24–33. 3 indexed citations
5.
Løchen, Alessandra, Diane Ashiru‐Oredope, Kieran Hand, et al.. (2023). Surveillance and Stewardship Approaches for COVID-19 Novel Therapeutics in England from 2021 to 2022 (ESPAUR Report). SHILAP Revista de lepidopterología. 2–2.
6.
Guy, Rebecca, Katie L. Hopkins, Alicia Demirjian, et al.. (2023). Antimicrobial Resistance in England 2017 to 2021 (ESPAUR Report 2021–22). SHILAP Revista de lepidopterología. 3–3. 1 indexed citations
7.
Nsonwu, Olisaeloka, Jocelyn Elmes, Dimple Chudasama, et al.. (2023). Increased rates of hospital-onset Staphylococcus aureus bacteraemia in National Health Service acute trusts in England between June 2020 and March 2021: a national surveillance review. Journal of Hospital Infection. 143. 33–37. 2 indexed citations
8.
Freeman, Rachel, Adam Doble, Gillian Hood, et al.. (2023). Appropriateness of acute-care antibiotic prescriptions for community-acquired infections and surgical antibiotic prophylaxis in England: analysis of 2016 national point prevalence survey data. Journal of Hospital Infection. 142. 115–129. 5 indexed citations
9.
Demirjian, Alicia, et al.. (2023). The impact of COVID-19 national restrictions on dental antibiotic dispensing trends and treatment activity in England: January 2016 to July 2021. JAC-Antimicrobial Resistance. 5(4). dlad081–dlad081. 1 indexed citations
10.
11.
Llewelyn, Martin, Detelina Grozeva, Philip Howard, et al.. (2022). Impact of introducing procalcitonin testing on antibiotic usage in acute NHS hospitals during the first wave of COVID-19 in the UK: a controlled interrupted time series analysis of organization-level data. Journal of Antimicrobial Chemotherapy. 77(4). 1189–1196. 4 indexed citations
12.
Bhattacharya, Alex, Simon M. Collin, James Stimson, et al.. (2021). Healthcare-associated COVID-19 in England: A national data linkage study. Journal of Infection. 83(5). 565–572. 39 indexed citations
13.
Sloot, Rosa, Olisaeloka Nsonwu, Dimple Chudasama, et al.. (2021). Rising rates of hospital-onset Klebsiella spp. and Pseudomonas aeruginosa bacteraemia in NHS acute trusts in England: a review of national surveillance data, August 2020–February 2021. Journal of Hospital Infection. 119. 175–181. 17 indexed citations
14.
Gerver, Sarah, Olisaeloka Nsonwu, Simon Thelwall, Colin Brown, & Russell Hope. (2021). Trends in rates of incidence, fatality and antimicrobial resistance among isolates of Pseudomonas spp. causing bloodstream infections in England between 2009 and 2018: results from a national voluntary surveillance scheme. Journal of Hospital Infection. 120. 73–80. 6 indexed citations
15.
Gerver, Sarah, Rebecca Guy, Kate Wilson, et al.. (2021). National surveillance of bacterial and fungal coinfection and secondary infection in COVID-19 patients in England: lessons from the first wave. Clinical Microbiology and Infection. 27(11). 1658–1665. 33 indexed citations
16.
Ellington, Matthew J., Sandra Reuter, Simon R. Harris, et al.. (2015). Emergent and evolving antimicrobial resistance cassettes in community-associated fusidic acid and meticillin-resistant Staphylococcus aureus. International Journal of Antimicrobial Agents. 45(5). 477–484. 41 indexed citations
17.
Kim, Sung-Hee, Sarah Gerver, Sarah Fidler, & Helen Ward. (2014). Adherence to antiretroviral therapy in adolescents living with HIV. AIDS. 28(13). 1945–1956. 308 indexed citations breakdown →
18.
Elmahdi, Rahma, et al.. (2014). Low levels of HIV test coverage in clinical settings in the UK: a systematic review of adherence to 2008 guidelines. Sexually Transmitted Infections. 90(2). 119–124. 51 indexed citations
19.
Elam, Gillian, et al.. (2009). Liminal identities: Caribbean men who have sex with men in London, UK. Culture Health & Sexuality. 11(3). 315–330. 11 indexed citations
20.
Elam, Gillian, et al.. (2008). HIV/AIDS-related stigma and discrimination: Accounts of HIV-positive Caribbean people in the United Kingdom. Social Science & Medicine. 67(5). 790–798. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Esther Buregyeya Breakdown of academic impact, for papers by Alicen B. Spaulding Breakdown of academic impact, for papers by Joseph I. Harwell Breakdown of academic impact, for papers by Nimalie D. Stone Breakdown of academic impact, for papers by Setegn Eshetie Breakdown of academic impact, for papers by Margaret Pereyra Breakdown of academic impact, for papers by Stacey Knobler Breakdown of academic impact, for papers by James S. Ngocho Breakdown of academic impact, for papers by Workeabeba Abebe Breakdown of academic impact, for papers by Vonthanak Saphonn
Rankless by CCL
2026